From FiercePharma: Continuing medical education (CME) has been bastardized by pharma funding, an HHS inspector general told Congress, and needs a complete overhaul. Lewis Morris, chief counsel for the HHS office of inspector general, said that industry doesn’t just shape the courses, it has also used CME to promote off-label uses. And Morris was just [...]
Filed under: medical education, pharmaceuticals | Tagged: CME, pharma | Leave a Comment »